
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
![]() | Portage Biotech Inc | 10.58 | 5.87 | 124.63% | 1,862,216 |
![]() | Ascent Solar Technologies Inc | 2.77 | 0.98 | 54.75% | 786,599 |
![]() | Hub Cyber Security Ltd | 0.0168 | 0.0049 | 41.18% | 474 |
![]() | Sensei Biotherapeutics Inc | 0.5749 | 0.1441 | 33.45% | 9,375,082 |
![]() | TransCode Therapeutics Inc | 0.67 | 0.15 | 28.85% | 3,587,110 |
![]() | Top Wealth Group Holding Ltd | 0.2238 | 0.041 | 22.43% | 3,874,227 |
![]() | ARB IOT Group Ltd | 0.85 | 0.151 | 21.60% | 6,180,706 |
![]() | QVC Group Inc | 0.2499 | 0.0397 | 18.89% | 12,876 |
![]() | Dolphin Entertainment Inc | 1.25 | 0.19 | 17.92% | 1,719,391 |
![]() | Prelude Therapeutics Inc | 0.80 | 0.1182 | 17.34% | 156,028 |
![]() | Marblegate Acquisition Corporation | 58.00 | 8.00 | 16.00% | 36,281 |
Full Year Revenue of $62.3 Million In-Line with Revised Revenue Guidance Continued to Diversify Customer Base with Leading Sell-Side Partners and Buy-Side Customers in New Verticals Management to Host Conference Call at 5:00 PM ET Today HOUSTON, March 27, 2025 /PRNewswire/ -- Direct Digital Holdings, Inc. (Nasdaq: DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced financial results for the fourth quarter and full year ended December 31, 2024.
First patient in Cohort four has been treated with TTX-MC138Ten patients have been treated with TTX-MC138 at escalating dose levelsAdditional patients being evaluated for eligibility for expanded enrollmentNo significant safety or dose limiting toxicities have been reportedBOSTON, March 27, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the first patient in Cohort 4 of its Phase I clinical trial has received their initial dose. TransCode also reported that two additional patients in Cohort 4 are scheduled to receive TTX-MC138. The therapeutic candidate being evaluated, TTX-MC138, ...
Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until September 16, 2025 (the "Compliance Period"), to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per share of the Company's ordinary shares is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. If the Company does not regain compliance with the minimum bid price requirement within the Compliance Period, the Company may ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced topline data from the Phase 3 EQUATOR study evaluating itolizumab in first-line treatment of patients with acute graft-versus-host disease (aGVHD). The study results did not demonstrate a meaningful difference in complete response (CR) or overall response rate (ORR) at Day 29 between patients treated with itolizumab and placebo; however, statistically significant and clinically meaningful benefit in longer-term outcomes were achieved, including complete response at Day 99, duration of complete response and failure-free survival. ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
![]() | Bitcoin | 87,475.75 | 590.15 | 0.68% | 1.74T | 3,286,245,192 |
![]() | Ethereum | 2,015.92 | 6.79 | 0.34% | 243.24B | 1,279,138,139 |
![]() | Tether USD | 0.99987 | -0.00013 | -0.01% | 141.91B | 275,512,949 |
![]() | Ripple | 2.35 | 0.00 | 0.00% | 135.74B | 688,279,205 |
![]() | Binance Coin | 638.86 | 21.00 | 3.40% | 100.9B | 547,844,428 |
![]() | Solana | 139.57 | 2.20 | 1.60% | 68.19B | 721,276,140 |
![]() | USD Coin | 0.9999 | 0.00 | 0.00% | 56.1B | 1,623,102,131 |
![]() | Dogecoin | 0.19236 | -0.00251 | -1.29% | 28.5B | 433,277,227 |
![]() | Cardano | 0.7413 | 0.0124 | 1.70% | 26.66B | 139,226,780 |
![]() | TRON | 0.234989 | 0.004198 | 1.82% | 20.23B | 126,377,094 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions